These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 19942270)
1. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. Landriscina M; Amoroso MR; Piscazzi A; Esposito F Gynecol Oncol; 2010 May; 117(2):177-82. PubMed ID: 19942270 [TBL] [Abstract][Full Text] [Related]
2. Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven Inflammation. Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Maddalena F; Condelli V; Landriscina M; Esposito F Adv Protein Chem Struct Biol; 2017; 108():163-198. PubMed ID: 28427560 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents. Landriscina M; Laudiero G; Maddalena F; Amoroso MR; Piscazzi A; Cozzolino F; Monti M; Garbi C; Fersini A; Pucci P; Esposito F Cancer Res; 2010 Aug; 70(16):6577-86. PubMed ID: 20647321 [TBL] [Abstract][Full Text] [Related]
4. Hsp90 inhibitors disrupt mitochondrial homeostasis in cancer cells. Neckers L; Kern A; Tsutsumi S Chem Biol; 2007 Nov; 14(11):1204-6. PubMed ID: 18022558 [TBL] [Abstract][Full Text] [Related]
5. Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer. Matassa DS; Amoroso MR; Lu H; Avolio R; Arzeni D; Procaccini C; Faicchia D; Maddalena F; Simeon V; Agliarulo I; Zanini E; Mazzoccoli C; Recchi C; Stronach E; Marone G; Gabra H; Matarese G; Landriscina M; Esposito F Cell Death Differ; 2016 Sep; 23(9):1542-54. PubMed ID: 27206315 [TBL] [Abstract][Full Text] [Related]
6. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells. Costantino E; Maddalena F; Calise S; Piscazzi A; Tirino V; Fersini A; Ambrosi A; Neri V; Esposito F; Landriscina M Cancer Lett; 2009 Jun; 279(1):39-46. PubMed ID: 19217207 [TBL] [Abstract][Full Text] [Related]
7. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Kang BH; Plescia J; Dohi T; Rosa J; Doxsey SJ; Altieri DC Cell; 2007 Oct; 131(2):257-70. PubMed ID: 17956728 [TBL] [Abstract][Full Text] [Related]
8. TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors. Kang BH BMB Rep; 2012 Jan; 45(1):1-6. PubMed ID: 22281005 [TBL] [Abstract][Full Text] [Related]
9. TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumors. Condelli V; Piscazzi A; Sisinni L; Matassa DS; Maddalena F; Lettini G; Simeon V; Palladino G; Amoroso MR; Trino S; Esposito F; Landriscina M Cancer Res; 2014 Nov; 74(22):6693-704. PubMed ID: 25239454 [TBL] [Abstract][Full Text] [Related]
10. Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma. Condelli V; Maddalena F; Sisinni L; Lettini G; Matassa DS; Piscazzi A; Palladino G; Amoroso MR; Esposito F; Landriscina M Oncotarget; 2015 Sep; 6(26):22298-309. PubMed ID: 26084290 [TBL] [Abstract][Full Text] [Related]
12. New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments. Li XT; Li YS; Shi ZY; Guo XL Life Sci; 2020 Aug; 254():117737. PubMed ID: 32376268 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models. Banerji U; Walton M; Raynaud F; Grimshaw R; Kelland L; Valenti M; Judson I; Workman P Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7023-32. PubMed ID: 16203796 [TBL] [Abstract][Full Text] [Related]
14. Guardian of the furnace: mitochondria, TRAP1, ROS and stem cell maintenance. Kadye R; Kramer AH; Joos-Vandewalle J; Parsons M; Njengele Z; Hoppe H; Prinsloo E IUBMB Life; 2014 Jan; 66(1):42-5. PubMed ID: 24382805 [TBL] [Abstract][Full Text] [Related]
15. TRAP1 revisited: novel localizations and functions of a 'next-generation' biomarker (review). Amoroso MR; Matassa DS; Sisinni L; Lettini G; Landriscina M; Esposito F Int J Oncol; 2014 Sep; 45(3):969-77. PubMed ID: 24990602 [TBL] [Abstract][Full Text] [Related]
16. Heat shock proteins in ovarian cancer: a potential target for therapy. Cohen M; Dromard M; Petignat P Gynecol Oncol; 2010 Oct; 119(1):164-6. PubMed ID: 20580418 [TBL] [Abstract][Full Text] [Related]
17. Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian Cancer. Criscuolo D; Avolio R; Calice G; Laezza C; Paladino S; Navarra G; Maddalena F; Crispo F; Pagano C; Bifulco M; Landriscina M; Matassa DS; Esposito F Cells; 2020 Mar; 9(4):. PubMed ID: 32235572 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells. Guzzo G; Sciacovelli M; Bernardi P; Rasola A Oncotarget; 2014 Dec; 5(23):11897-908. PubMed ID: 25564869 [TBL] [Abstract][Full Text] [Related]
19. New insights into TRAP1 pathway. Matassa DS; Amoroso MR; Maddalena F; Landriscina M; Esposito F Am J Cancer Res; 2012; 2(2):235-48. PubMed ID: 22432061 [TBL] [Abstract][Full Text] [Related]
20. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1. Sanchez-Martin C; Menon D; Moroni E; Ferraro M; Masgras I; Elsey J; Arbiser JL; Colombo G; Rasola A Antioxid Redox Signal; 2021 Mar; 34(7):505-516. PubMed ID: 32438819 [No Abstract] [Full Text] [Related] [Next] [New Search]